Anaphylatoxin formation by contact activation of plasma. I. Activation by zymosan without participation of antibody.
D000042:Absorption; D000707:Anaphylaxis; D000818:Animals; D000906:Antibodies; D000917:Antibody Formation; D000936:Antigen-Antibody Complex; D001798:Blood Proteins / Q000032:analysis; D003165:Complement System Proteins; D003911:Dextrans / Q000494:pharmacology; D004912:Erythrocytes / Q000276:immunology; D006003:Glycogen / Q000494:pharmacology; D006386:Hemagglutination Tests; D006462:Hemolytic Plaque Technique; D007082:Ileum / Q000276:immunology; D007106:Immune Sera; D007122:Immunoelectrophoresis; D009119:Muscle Contraction; D009584:Nitrogen / Q000032:analysis; D010047:Ovalbumin; D010455:Peptides; D051381:Rats; D013618:Tachyphylaxis; D014118:Toxins, Biological / Q000096:biosynthesis*; D015054:Zymosan / Q000494:pharmacology*
D000906:Antibodies; D000936:Antigen-Antibody Complex; D001798:Blood Proteins; D003911:Dextrans; D007106:Immune Sera; D010455:Peptides; D014118:Toxins, Biological; D006003:Glycogen; D010047:Ovalbumin; D003165:Complement System Proteins; D015054:Zymosan; D009584:Nitrogen